In addition, studies of patients with Alzheimer’s disease demonstrate the same activation steps leading to bradykinin formation, namely, the formation of two enzymes, activated factor XII and plasma kallikrein. The gene discussed is KLK4; the disease is early-onset autosomal dominant Alzheimer disease.